Accessibility Menu
Medical Marijuana Stock Quote

Medical Marijuana (OTC: MJNA)

$0.00
(-33.3%)
-0.00
Price as of October 22, 2025, 3:56 p.m. ET

KEY DATA POINTS

Current Price
$0
Daily Change
(-33.3%) $0.00
Day's Range
$0 - $0
Previous Close
$0
Open
$0
Beta
1.04
Volume
13,876,435
Average Volume
48,171,381
Market Cap
1.1M
Market Cap / Employee
$0.00M
52wk Range
$0 - $0
Revenue
-
Gross Margin
0.78%
Dividend Yield
N/A
EPS
-$0
CAPs Rating
-
Industry
Healthcare Providers and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Medical Marijuana Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
MJNA-80%-98.51%-56.87%-99%
S&P+14.5%+93.32%+14.09%+410%

Medical Marijuana Company Info

Medical Marijuana, Inc. engages in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids. It operates through the following divisions: Medical Marijuana Inc, HempMeds and Kannaway. Medical Marijuana Inc operates as the parent company of all divisions. HempMeds distributes hemp oil in the US and internationally. Kannaway is a direct selling division which sells Cannabidiol (CBD) products worldwide. The company was founded in 2003 and is headquartered in San Diego, CA.

News & Analysis

Financial Health

General

Q1 2025YOY Change
Revenue$2.79M-31.6%
Gross Profit$2.17M-33.3%
Gross Margin77.89%-1.9%
Market Cap$1.71M-82.9%
Market Cap / Employee$0.08M0.0%
Employees220.0%
Net Income$0.44M104.5%
EBITDA$0.27M258.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q1 2025YOY Change
Net Cash$0.97M-12.7%
Accounts Receivable$0.31M-31.2%
Inventory1.4-22.8%

Liabilities

Q1 2025YOY Change
Long Term Debt$2.94M-3.1%
Short Term Debt$0.00M0.0%

Ratios

Q1 2025YOY Change
Return On Assets-0.61%4.3%
Return On Invested Capital-41.86%-18.4%

Cash Flow

Q1 2025YOY Change
Free Cash Flow$0.06M-83.1%
Operating Free Cash Flow$0.06M-83.1%

Valuation

MetricQ2 2024Q3 2024Q4 2024Q1 2025YoY Change
Price to Book0.170.110.050.04-84.14%
Price to Sales0.570.440.180.16-79.10%
Price to Tangible Book Value-6.28-3.32-1.16-0.87-83.79%
Price to Free Cash Flow TTM2.773.21-
Enterprise Value to EBITDA32.4882.45856.5515.54-117.61%
Free Cash Flow Yield36.1%31.1%-
Return on Equity-8.3%-6.5%-1.3%-0.8%-87.44%
Total Debt$3.02M$3.10M$2.85M$2.94M-3.08%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.